leisure time -WSS

leisure time

author：knowledge 2025-09-27 23:54:06 - browse：569

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies.

Even so, three sectors still managed to see strong deal flow and prices: med spa, cardiology, and clinical trial sites, according to a new PitchBook report analyzing private equity investments in health care services in 2023. Each of the three niches continue to generate buzz among investors, even as other areas fizzle.

It’s not that those three industries are perfect fits for private equity, it’s that the more obvious areas like autism therapists and physician practices are struggling with high interest rates and regulatory scrutiny, said Rebecca Springer, PitchBook’s lead health care analyst.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： FDA authorizes Novavax’s updated Covid

explore

WSS

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Phenylephrine and the overlooked value of the placebo effect

Millions may soon lose Medicaid when they don't have to

Chemotherapy drug shortage eases slightly but still widespread

FDA authorizes Novavax’s updated Covid

Millions may soon lose Medicaid when they don't have to

Wikipedia

leisure time

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Eli Lilly’s Mounjaro succeeds in second weight

Medical records are filled with copy

Can medical device makers keep up in the race to treat obesity?

How to save PrEP access — and even expand it

VC firm General Catalyst wants to buy a health system

Duchenne breakthrough therapy leaves behind pioneering families

Sea level rise could wash away turtle breeding grounds around the world, researchers say

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

focus

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Physician executives need more than on

FDA approves first new drug developed for postpartum depression

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Was Amgen transparent enough on FDA's concern on cancer drug?

AI can decode, harness the power of the humane immune system

Wikipedia

explore

focus

focus